Methods for improving drug disposition

Details for Australian Patent Application No. 2006212417 (hide)

Owner Novartis AG

Inventors Nick, Hanspeter; Gross, Gerhard; Camenisch, Gian P.

Agent Davies Collison Cave

Pub. Number AU-A-2006212417

PCT Pub. Number WO2006/084683

Priority 60/651,684 10.02.05 US

Filing date 8 February 2006

Wipo publication date 17 August 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 39/04 (2006.01) General protective or antinoxious agents

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084683 Priority application(s): WO2006/084683

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212422-HIV protease inhibitors

2006212416-Method and apparatus for fluidizing a fluidized bed